91原创

Skip to content
Join our Newsletter

Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some and future products.

Lilly said Thursday it will expand a Kenosha County, Wisconsin, factory it bought early this year, and the investment will help meet growing demand for injectable products like its diabetes and obesity drugs, Mounjaro and .

Those drugs brought in a for Lilly in this year鈥檚 third quarter.

The drugmaker plans to start construction of the expansion next year.

Lilly also announced other multibillion-dollar manufacturing expansion projects near its Indianapolis headquarters earlier this year.

Eli Lilly and Co. said Thursday that it has slated more than $23 billion to construct, expand or acquire manufacturing sites worldwide since 2020.

The Associated Press